Trials / Recruiting
RecruitingNCT06193668
Overfeeding Induced Fat-tissue Stimulation
Short-term High-fat Overnutrition Induces Insulin Resistance in White Adipose Tissue
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- German Diabetes Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Type 2 diabetes is the most common metabolic disease worldwide, characterized by hyperglycemia, decreased whole body insulin sensitivity, and white adipose tissue (WAT) dysfunction. A key factor in its development is chronic overnutrition, usually with a high-fat diet (HFD), leading to disturbances of glucose and lipid metabolism. However, the mechanism of short-term HFD-induced tissue-specific insulin resistance remains poorly understood. This project aims to further unravel the underlying mechanisms of short-term HFD overnutrition-mediated WAT insulin resistance. The model described here corresponds to a randomized, single- blinded parallel-grouped trial, consisting of two interventions: a macronutrient-balanced diet and or a hypercaloric diet over three weeks in order to investigate differences in interorgan fatty acid and glucose metabolism between the studied groups. Based on recent studies, the hypothesis is that 21-day hypercaloric HFD induces WAT insulin resistance via a diacylglycerol, novel protein kinase C-insulin receptor signaling model in both fasting and insulin-stimulated states.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | High-fat overnutrition | Overnutrition: 40% higher lipid consumption per day than required |
| BEHAVIORAL | Normocaloric macronutrient-balanced nutrition | Normocaloric, macronutrient-balanced nutrition: Calories requirement for weight maintenance \[(kcal/d) 55% carbohydrates, 15% proteins, 30% fat\] |
Timeline
- Start date
- 2024-01-31
- Primary completion
- 2025-12-31
- Completion
- 2030-12-31
- First posted
- 2024-01-05
- Last updated
- 2024-03-01
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT06193668. Inclusion in this directory is not an endorsement.